Literature DB >> 20923960

Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects.

Aidar R Gosmanov1, Dawn D Smiley, Gonzalo Robalino, Joselita Siquiera, Bobby Khan, Ngoc-Anh Le, Riyaz S Patel, Arshed A Quyyumi, Limin Peng, Abbas E Kitabchi, Guillermo E Umpierrez.   

Abstract

We compared the effects of high and low oral and intravenous (iv) fat load on blood pressure (BP), endothelial function, autonomic nervous system, and oxidative stress in obese healthy subjects. Thirteen obese subjects randomly received five 8-h infusions of iv saline, 20 (32 g, low iv fat) or 40 ml/h intralipid (64 g, high iv fat), and oral fat load at 32 (low oral) or 64 g (high oral). Systolic BP increased by 14 ± 10 (P = 0.007) and 12 ± 9 mmHg (P = 0.007) after low and high iv lipid infusions and by 13 ± 17 (P = 0.045) and 11 ± 11 mmHg (P = 0.040) after low and high oral fat loads, respectively. The baseline flow-mediated dilation was 9.4%, and it decreased by 3.8 ± 2.1 (P = 0.002) and 4.1 ± 3.1% (P < 0.001) after low and high iv lipid infusion and by 3.8 ± 1.8 (P = 0.002) and 5.0 ± 2.5% (P < 0.001) after low and high oral fat load, respectively. Oral and iv fat load stimulated oxidative stress, increased heart rate, and decreased R-R interval variability. Acute iv fat load decreased blood glucose by 6-10 mg/dl (P < 0.05) without changes in insulin concentration, whereas oral fat increased plasma insulin by 3.7-4.0 μU/ml (P < 0.01) without glycemic variations. Intravenous saline and both oral and iv fat load reduced leptin concentration from baseline (P < 0.01). In conclusion, acute fat load administered orally or intravenously significantly increased blood pressure, altered endothelial function, and activated sympathetic nervous system by mechanisms not likely depending on changes in leptin, glucose, and insulin levels in obese healthy subjects. Thus, fat load, independent of its source, has deleterious hemodynamic effects in obese subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20923960      PMCID: PMC3006255          DOI: 10.1152/ajpendo.00469.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  44 in total

1.  Effect of fat and carbohydrate consumption on endothelial function.

Authors:  P J Ong; T S Dean; C S Hayward; P L Della Monica; T A Sanders; P Collins
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

2.  Hemodynamic effects of lipids in humans.

Authors:  M P Stojiljkovic; D Zhang; H F Lopes; C G Lee; T L Goodfriend; B M Egan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-06       Impact factor: 3.619

3.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.

Authors:  H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 4.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

5.  Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension.

Authors:  L Ghiadoni; Y Huang; A Magagna; S Buralli; S Taddei; A Salvetti
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

6.  Effect of a single high-fat meal on endothelial function in healthy subjects.

Authors:  R A Vogel; M C Corretti; G D Plotnick
Journal:  Am J Cardiol       Date:  1997-02-01       Impact factor: 2.778

Review 7.  New parenteral lipid emulsions for clinical use.

Authors:  Dan L Waitzberg; Raquel Susana Torrinhas; Thiago Manzoni Jacintho
Journal:  JPEN J Parenter Enteral Nutr       Date:  2006 Jul-Aug       Impact factor: 4.016

8.  Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion.

Authors:  R J Grekin; C J Dumont; A P Vollmer; S W Watts; R C Webb
Journal:  Am J Physiol       Date:  1997-07

9.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

Authors:  T Inoguchi; P Li; F Umeda; H Y Yu; M Kakimoto; M Imamura; T Aoki; T Etoh; T Hashimoto; M Naruse; H Sano; H Utsumi; H Nawata
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

10.  High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study.

Authors:  A Fagot-Campagna; B Balkau; D Simon; J M Warnet; J R Claude; P Ducimetière; E Eschwège
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

View more
  19 in total

1.  Substitution of standard soybean oil with olive oil-based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects.

Authors:  Joselita Siqueira; Dawn Smiley; Christopher Newton; Ngoc-Anh Le; Aidar R Gosmanov; Ronnie Spiegelman; Limin Peng; Samantha J Osteen; Dean P Jones; Arshed A Quyyumi; Thomas R Ziegler; Guillermo E Umpierrez
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

2.  Acute high-fat feeding does not prevent the improvement in glucose tolerance after resistance exercise in lean individuals.

Authors:  Christopher S Shaw; Natalie M Cooper; Oliver Shaw; Paulo Salomao; Anton J M Wagenmakers
Journal:  Eur J Appl Physiol       Date:  2011-03-05       Impact factor: 3.078

3.  A double-blind, randomized clinical trial comparing soybean oil-based versus olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition.

Authors:  Guillermo E Umpierrez; Ronnie Spiegelman; Vivian Zhao; Dawn D Smiley; Ingrid Pinzon; Daniel P Griffith; Limin Peng; Timothy Morris; Menghua Luo; Hermes Garcia; Christopher Thomas; Christopher A Newton; Thomas R Ziegler
Journal:  Crit Care Med       Date:  2012-06       Impact factor: 7.598

4.  Vascular effects of intravenous intralipid and dextrose infusions in obese subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Limin Peng; Joselita Siquiera; Gonzalo Robalino; Christopher Newton; Guillermo E Umpierrez
Journal:  Metabolism       Date:  2012-04-05       Impact factor: 8.694

Review 5.  Medical nutrition therapy in hospitalized patients with diabetes.

Authors:  Aidar R Gosmanov; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

6.  Higher recipient body mass index is associated with post-transplant delayed kidney graft function.

Authors:  Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist; Elani Streja; Mahesh Krishnan; Kamyar Kalantar-Zadeh
Journal:  Kidney Int       Date:  2011-04-27       Impact factor: 10.612

7.  Postprandial lipids accelerate and redirect nitric oxide consumption in plasma.

Authors:  Kurt Vrancken; Hobe J Schroeder; Lawrence D Longo; Gordon G Power; Arlin B Blood
Journal:  Nitric Oxide       Date:  2016-03-25       Impact factor: 4.427

8.  Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin.

Authors:  Jeanethe A Anguizola; Sara B G Basiaga; David S Hage
Journal:  Curr Metabolomics       Date:  2013-09-01

Review 9.  Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins.

Authors:  Sameer Ansar; Juraj Koska; Peter D Reaven
Journal:  Cardiovasc Diabetol       Date:  2011-07-07       Impact factor: 9.951

10.  Postprandial effect of dietary fat quantity and quality on arterial stiffness and wave reflection: a randomised controlled trial.

Authors:  Fiona E Lithander; Louise K Herlihy; Deirdre M Walsh; Emma Burke; Vivion Crowley; Azra Mahmud
Journal:  Nutr J       Date:  2013-07-10       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.